[HTML][HTML] The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and …
Background Chloroquine remains the mainstay of treatment for Plasmodium vivax malaria
despite increasing reports of treatment failure. We did a systematic review and meta …
despite increasing reports of treatment failure. We did a systematic review and meta …
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual …
RJ Commons, JA Simpson, K Thriemer… - Lancet Infectious …, 2018 - ora.ox.ac.uk
Background Chloroquine remains the mainstay of treatment for Plasmodium vivax malaria
despite increasing reports of treatment failure. We did a systematic review and meta …
despite increasing reports of treatment failure. We did a systematic review and meta …
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual …
RJ Commons, JA Simpson, K Thriemer… - Lancet Infectious …, 2018 - archive.lstmed.ac.uk
BACKGROUND Chloroquine remains the mainstay of treatment for Plasmodium vivax
malaria despite increasing reports of treatment failure. We did a systematic review and meta …
malaria despite increasing reports of treatment failure. We did a systematic review and meta …
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual …
RJ Commons, JA Simpson, K Thriemer… - The Lancet. Infectious …, 2018 - stacks.cdc.gov
Background Chloroquine remains the mainstay of treatment for Plasmodium vivax malaria
despite increasing reports of treatment failure. We did a systematic review and meta …
despite increasing reports of treatment failure. We did a systematic review and meta …
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual …
RJ Commons, JA Simpson, K Thriemer, GS Humphreys… - 2018 - arca.fiocruz.br
Background Chloroquine remains the mainstay of treatment for Plasmodium vivax malaria
despite increasing reports of treatment failure. We did a systematic review and meta …
despite increasing reports of treatment failure. We did a systematic review and meta …
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: A WorldWide Antimalarial Resistance Network systematic review and individual …
RJ Commons, JA Simpson… - The Lancet …, 2018 - researchers.cdu.edu.au
Background: Chloroquine remains the mainstay of treatment for Plasmodium vivax malaria
despite increasing reports of treatment failure. We did a systematic review and meta …
despite increasing reports of treatment failure. We did a systematic review and meta …
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a worldwide antimalarial resistance network systematic review and individual …
RJ Commons, JA Simpson, K Thriemer, GS Humphreys… - 2018 - cabidigitallibrary.org
Background: Chloroquine remains the mainstay of treatment for Plasmodium vivax malaria
despite increasing reports of treatment failure. We did a systematic review and meta …
despite increasing reports of treatment failure. We did a systematic review and meta …
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual …
RJ Commons, JA Simpson, K Thriemer… - The Lancet. Infectious …, 2018 - europepmc.org
Background Chloroquine remains the mainstay of treatment for Plasmodium vivax malaria
despite increasing reports of treatment failure. We did a systematic review and meta …
despite increasing reports of treatment failure. We did a systematic review and meta …
[HTML][HTML] The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and …
RJ Commons, JA Simpson, K Thriemer… - The Lancet Infectious …, 2018 - Elsevier
Background Chloroquine remains the mainstay of treatment for Plasmodium vivax malaria
despite increasing reports of treatment failure. We did a systematic review and meta …
despite increasing reports of treatment failure. We did a systematic review and meta …
[HTML][HTML] The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and …
RJ Commons, JA Simpson, K Thriemer… - The Lancet. Infectious …, 2018 - ncbi.nlm.nih.gov
Background Chloroquine remains the mainstay of treatment for Plasmodium vivax malaria
despite increasing reports of treatment failure. We did a systematic review and meta …
despite increasing reports of treatment failure. We did a systematic review and meta …